Robert M. Cooper, PhD

Cardiologist
Liverpool John Moores University, United Kingdom

Poster(s):

• (31) Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM
  Wednesday, October 29, 2025